VivoSim Labs VIVS
NASDAQ VIVS
$0.16 +0.00 (+1.34%)
As of: Oct 19, 2026 · 3:56 PM EDT

VivoSim Labs (VIVS) Short-term Investments (2022)

Updated

VivoSim Labs' Short-term Investments came in at $10 million for fiscal Q2 2023 (quarter ended Sep 30, 2022), up 1.0% from the prior quarter.

Analysis

VivoSim Labs (VIVS) Short-term Investments (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.17 Bn 35.87 Bn 1.44 Bn
2 Medpace Holdings 17.45 Bn 15.51 Bn 201.64 Mn
3 Charles River Laboratories International 14.37 Bn 13.56 Bn 363.37 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn
5 Fortrea Holdings 2.12 Bn 1.50 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 625.60 Mn -136.48 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 65.60 Mn 40.68 Mn 7.70 Mn
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn
10 VivoSim Labs 832,550.47 -16.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 10.00 Mn
Jun 30, 2022 9.90 Mn
API Access

VivoSim Labs Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=VIVS&period=max&api_key=YOUR_API_KEY